“It seems enormously valuable to me.” Perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing

Abstract Background Onset-predictive biomarker tests (OPBT) in genetic frontotemporal dementia (FTD) may be used to recruit mutation carriers into preventive clinical trials before symptoms manifest. This would require disclosure of OPBT results to potential participants. This study investigates the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Charlotte H. Graafland, Harro Seelaar, Jessica L. Panman, Lize C. Jiskoot, Tjitske Kleefstra, Jackie M. Poos, Edo Richard, Maartje H.N. Schermer, John C. van Swieten, Laura Donker Kaat, Eline M. Bunnik
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-05-01
coleção:	Alzheimer’s Research & Therapy
Assuntos:	Onset prediction Frontotemporal dementia Biomarker Ethics Genetic counselling Clinical trial recruitment
Acesso em linha:	https://doi.org/10.1186/s13195-025-01749-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!